References
- 1. Bomford R. Immunomodulators from plants and fungi. Phytother Res. 1988; 2(4):159-64.
- 2. Saroj P, Verma M, Jha K, Pal M. An overview on immunomodulation. J Adv Sci Res. 2012; 3(1):7-12.
- 3. Jantan I, Ahmad W, Bukhari SN. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015; 6:655.
- 4. Dobrange E, Peshev D, Loedolff B, Van den Ende W. Fructans as Immunomodulatory and Antiviral Agents: The Case of Echinacea. Biomolecules. 2019; 9(10):615.
- 5. Jaradat NA. Review of the taxonomy, ethnobotany, phytochemistry, phytotherapy and phytotoxicity of germander plant (Teucrium polium L.). Medicine. 2015; 3:4.
- 6. Esmaeili MA, Yazdanparast R. Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets. J Ethnopharm. 2004; 95(1):27-30.
- 7. Ljubuncic P, Dakwar S, Portnaya I, et al. Aqueous extracts of Teucrium polium possess remarkable antioxidant activity in vitro. Evid Based Complement Alternat Med. 2006; 3(3):329-38.
- 8. Darabpour E, Motamedi H, Nejad SMS. Antimicrobial properties of Teucrium polium against some clinical pathogens. Asian Pac J Trop Med. 2010; 3(2):124-7.
- 9. Rajabalian S. Methanolic extract of Teucrium polium L potentiates the cytotoxic and apoptotic effects of anticancer drugs of vincristine, vinblastine and doxorubicin against a panel of cancerous cell lines. Exp Oncol. 2008; 30(2):133-8.
- 10. Tariq M, Ageel A, Al-Yahya M, Mossa J, Al-Said M. Anti-inflammatory activity of Teucrium polium. Int J Tissue React. 1989; 11(4):185-8.
- 11. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000; 31(1):241-6.
- 12. Stankovic MS, Niciforovic N, Mihailovic V, Topuzovic M, Solujic S. Antioxidant activity, total phenolic content and flavonoid concentrations of different plant parts of Teucrium polium L. subsp. polium. Acta Soc Bot Pol. 2012; 81(2):117-122.
- 13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63.
- 14. Verma A, Prasad KN, Singh AK, et al. Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis. J Microbiol Methods. 2010; 81(2): 175-8.
- 15. Petruzziello A, Samantha M, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016; 22:7824.
- 16. Organization WH. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization; 2016.
- 17. Santantonio T, Wiegand J, Gerlach JT. Acute hepatitis C: current status and remaining challenges. J Hepatol. 2008; 49(4):625-33.
- 18. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1):41-52.
- 19. Thimme R, Bukh J, Spangenberg HC, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 2002; 99(24):15661-8.
- 20. B Dustin L. Innate and adaptive immune responses in chronic HCV infection. Curr Drug Targets. 2017; 18(7): 826-43.
- 21. Iken K, Huang L, Bekele H, Schmidt EV, Koziel MJ. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology. 2006; 346(2):363-72.
- 22. Barathan M, Mohamed R, Yong YK, et al. Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion. Cells. 2018; 7(10):165.
- 23. Luxenburger H, Neumann-Haefelin C, Thimme R, Boettler T. HCV-specific T cell responses during and after chronic HCV infection. Viruses. 2018; 10(11):645.
- 24. Saeidi A, Zandi K, Cheok YY, et al. T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses. Front Immunol. 2018; 9:2569.
- 25. Brattig NW, Diao GJ, Berg PA. Immunoenhancing effect of flavonoid compounds on lymphocyte proliferation and immunoglobulin synthesis. Int J Immunopharmacol. 1984; 6(3):205-15.
- 26. Chiang L-C, Ng LT, Chiang W, Chang M-Y, Lin C-C. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003; 69(07): 600-4.
- 27. Norian R, Delirezh N, Azadmehr A. Evaluation of proliferation and cytokines production by mitogen-stimulated bovine peripheral blood mononuclear cells. Vet Res Forum. 2015; 6(4):265-71.
- 28. Jose J, Sudhakaran S, Sumesh Kumar TM, Jayaraman S, Jayadevi Variyar E. Study of in vitro immunomodulatory effect of flavonoid isolated from Phyllanthus niruri on human blood lymphocytes and evaluation of its antioxidant potential. Int J Pharmacogn Phytochem Res. 2014; 6(2): 284-9.
- 29. Berg AU, Baron DP, Berg PA. Immunomodulating properties of cianidanol on responsiveness and function of human peripheral blood T-cells and K-cells. Int J Immunopharmacol. 1988; 10(4):387-94.
- 30. Vallotton JJ, Frei PC. Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. Infect Immun. 1981; 32(2):432-7.
- 31. Ruckstuhl M, Beretz A, Anton R, Landry Y. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biocheml pharma. 1979; 28(4):535-8.